| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/07/2002 | WO2000069835A3 Process for manufacturing diazepine derivatives |
| 03/07/2002 | US20020028953 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 03/07/2002 | US20020028949 Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028939 Reacting lactone with diamine by heating; polyurethane polymerization catalyst |
| 03/07/2002 | US20020028823 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
| 03/07/2002 | US20020028817 Platelet derived growth factors (PDGF); 1,2-dimethyl-6-(2-thiophene)imidazolo(5,4-g)quinoxaline preparations for example; use treating proliferative malignant and non-malignant diseases; stents |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | US20020028814 Aza compounds, pharmaceutical compositions and methods of use |
| 03/07/2002 | US20020028782 Cardiovascular disorders; nervous system disorders |
| 03/07/2002 | DE10042092A1 Antikonvulsiv wirkende 2,5-Dihydro-pyrazolo(3,4-d)pyrimidin-4-one und Verfahren zu deren Darstellung Anticonvulsant acting 2,5-dihydro-pyrazolo (3,4-d) pyrimidin-4-one and processes for their representation |
| 03/07/2002 | DE10041903A1 New aconitic acid derivatives useful as ultraviolet absorbers, fluorescent dyes, marker dyes, optical brighteners and intermediates for pharmaceutical, veterinary or plant protection agents |
| 03/07/2002 | CA2434744A1 Novel metallotexaphyrin derivatives |
| 03/07/2002 | CA2420288A1 2,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonvulsive action and methods for producing the same |
| 03/07/2002 | CA2419623A1 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | CA2419616A1 Novel ester or amide derivatives |
| 03/06/2002 | EP1184385A1 1-[Alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridin-4-yl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 03/06/2002 | EP1184384A1 1-(Alkyl), 1-((heteroaryl)alkyl) and 1-((aryl)alkyl)-7-pyridin-4-ylimidazo(1,2a)pyrimidin-5(1H)-one derivatives |
| 03/06/2002 | EP1184383A1 9-[Alkyl], 9-[(heteroaryl)alkyl] and 9-[(aryl)alkyl]-2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 03/06/2002 | EP1183317A2 Process for the preparation of herbicidal derivatives |
| 03/06/2002 | EP1183259A2 Azepinoindole derivatives, the production and use thereof |
| 03/06/2002 | EP1183258A1 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 03/06/2002 | EP1183257A1 Triazolopyrimidinol compounds and salts thereof |
| 03/06/2002 | EP1183243A1 Short-acting benzodiazepines |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183033A1 Pyrrolotriazine inhibitors of kinases |
| 03/06/2002 | EP1183030A1 Methods of making and using n-desmethylzopiclone |
| 03/06/2002 | EP0743945B1 Heterocyclic compounds and their preparation and use |
| 03/06/2002 | CN1339037A Pyrrolobenzodiazepine carboxyamide vasporessin agonists |
| 03/06/2002 | CN1339036A Thienylbenzoylbenzapines as vasporessin agonists |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338738A Optical recording media and porphinoid compound |
| 03/06/2002 | CN1080291C Preparation of mixed crystals and solid of 1,4-diketopyrrolopyrroles |
| 03/06/2002 | CN1080265C Process for preparation of 7-alkoxyalkyl-1,2,4-triazolo (1,5-A) pyrimidine derivatives |
| 03/06/2002 | CN1080263C Method and compositions for the synthesis of dioxolane nucleosides with 'beta'-configuration |
| 03/05/2002 | US6353107 1-alkoxy-polyallkyl-piperidine derivatives and their use as polymerization regulators |
| 03/05/2002 | US6352990 CRF receptor antagonists and methods relating thereto |
| 03/05/2002 | US6352958 Pre- and post-emergence herbicides |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 02/28/2002 | WO2002017019A2 Oxime sulfonate and n-oxyimidosulfonate photoacid generators and photoresists comprising same |
| 02/28/2002 | WO2002016366A1 Copper or iron chlorophyllin sodium, pulp, aqueous pigment solution, paper yarn and process for producing the same |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002016364A1 Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence |
| 02/28/2002 | WO2002016363A1 Imidazolophthalazine derivatives as ligands for gabaa receptors |
| 02/28/2002 | WO2002016339A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016144A1 Optical information recording medium |
| 02/28/2002 | WO2002015909A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | WO2002015893A2 Treatment of wounds |
| 02/28/2002 | WO2002015697A2 Fungicidal formulation |
| 02/28/2002 | WO2001074741A3 Catalytic asymmetric desymmetrization of meso compounds |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001017614A3 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | US20020025966 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 02/28/2002 | US20020025956 Nervous system, psychological disorders |
| 02/28/2002 | DE10039610A1 Azepinoindole derivatives are PARP inhibitors and are useful for the treatment of neurodegenerative diseases, ischemia, tumor, septic shock, inflammation, rheumatic diseases, ARDS and diabetes mellitus |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | CA2420217A1 Fungicidal formulation |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | CA2415791A1 Treatment of wounds |
| 02/28/2002 | CA2415182A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/27/2002 | EP1181335A1 Extended rhodamine compounds useful as fluorescent labels |
| 02/27/2002 | EP1181294A1 Novel derivatives and analogues of galanthamin |
| 02/27/2002 | EP1181293A1 Cucurbiturils and method for synthesis |
| 02/27/2002 | EP1181292A1 Pyrozolo [3,4-d][1,2,3] triazines with an anticonvulsive action and methods for producing the same |
| 02/27/2002 | EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides |
| 02/27/2002 | EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 02/27/2002 | EP1023399A4 Novel methods of syntheses of phthalocyanine compounds |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | CN1337963A Pirazino (aza) indole derivatives |
| 02/27/2002 | CN1079796C Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/26/2002 | US6350871 Crystallization of compound in solvent with dissolving to form solution, saturation, seeding, evaporation and crystallization |
| 02/26/2002 | US6350786 Complexes significantly increase the bioavailability of poorly soluble therapeutically active compounds |
| 02/26/2002 | US6350772 Treatment of auto-immune diseases by photochemotherapy |
| 02/26/2002 | US6350770 Microbiocides, insecticides |
| 02/26/2002 | US6350751 Therapeutic agents |
| 02/26/2002 | US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014321A1 Use of stat-6 inhibitors as therapeutic agents |
| 02/21/2002 | WO2002014319A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors |
| 02/21/2002 | WO2001083423A3 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 02/21/2002 | WO2001030967A3 Fluorescent cobalamins and uses thereof |
| 02/21/2002 | US20020022732 Reacting diether compound with acylating agent comprising acid anhydride or acid halide derivative to form pyrazole derivative |
| 02/21/2002 | US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/21/2002 | US20020022632 For therapy of anxiety, depression, and other psychiatric, neurological disorders, immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | US20020022619 Administering to the mammal suffering from anxiety, depression and other disorders related to excessive corticotropin releasing factor an effective amount of tricyclic pyridine or pyrimidine derivatives |
| 02/21/2002 | US20020022614 Thrombin or factor Xa inhibitors |
| 02/21/2002 | US20020022575 Dialkyl-halogenophenyl-substituted ketoenols |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |